111 related articles for article (PubMed ID: 15099658)
1. Cross-generational effects on gender differences in psychoactive drug abuse and dependence.
Holdcraft LC; Iacono WG
Drug Alcohol Depend; 2004 May; 74(2):147-58. PubMed ID: 15099658
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
[TBL] [Abstract][Full Text] [Related]
3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
4. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder.
McCormick B; Blum N; Hansel R; Franklin JA; St John D; Pfohl B; Allen J; Black DW
Compr Psychiatry; 2007; 48(5):406-12. PubMed ID: 17707247
[TBL] [Abstract][Full Text] [Related]
5. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
Warner LA; Alegría M; Canino G
Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the latent class structure of cannabis problems among adult men and women who have used cannabis repeatedly.
Grant JD; Scherrer JF; Neuman RJ; Todorov AA; Price RK; Bucholz KK
Addiction; 2006 Aug; 101(8):1133-42. PubMed ID: 16869843
[TBL] [Abstract][Full Text] [Related]
7. Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology.
Rehm J; Room R; van den Brink W; Kraus L
Eur Neuropsychopharmacol; 2005 Aug; 15(4):389-97. PubMed ID: 15955677
[TBL] [Abstract][Full Text] [Related]
8. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study.
Ringen PA; Melle I; Birkenaes AB; Engh JA; Faerden A; Jónsdóttir H; Nesvåg R; Vaskinn A; Friis S; Larsen F; Opjordsmoen S; Sundet K; Andreassen OA
Acta Psychiatr Scand; 2008 Feb; 117(2):133-8. PubMed ID: 18081921
[TBL] [Abstract][Full Text] [Related]
9. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
Chung T; Martin CS
J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
[TBL] [Abstract][Full Text] [Related]
10. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Lynskey MT; Agrawal A
Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
[TBL] [Abstract][Full Text] [Related]
12. Birth cohort differences in features of antisocial alcoholism among men and women.
Stoltenberg SF; Hill EM; Mudd SA; Blow FC; Zucker RA
Alcohol Clin Exp Res; 1999 Dec; 23(12):1884-91. PubMed ID: 10630606
[TBL] [Abstract][Full Text] [Related]
13. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
Westermeyer J; Thuras P
Am J Drug Alcohol Abuse; 2005; 31(1):93-110. PubMed ID: 15768573
[TBL] [Abstract][Full Text] [Related]
14. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
Kendler KS; Myers J; Prescott CA
Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
[TBL] [Abstract][Full Text] [Related]
15. Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5 years.
Culverhouse R; Bucholz KK; Crowe RR; Hesselbrock V; Nurnberger JI; Porjesz B; Schuckit MA; Reich T; Bierut LJ
Arch Gen Psychiatry; 2005 Jul; 62(7):753-60. PubMed ID: 15997016
[TBL] [Abstract][Full Text] [Related]
16. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
Kolodziej ME; Griffin ML; Najavits LM; Otto MW; Greenfield SF; Weiss RD
Drug Alcohol Depend; 2005 Nov; 80(2):251-7. PubMed ID: 15876498
[TBL] [Abstract][Full Text] [Related]
17. Are clinical impressions of adolescent substance use accurate?
Wilson CR; Sherritt L; Gates E; Knight JR
Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
[TBL] [Abstract][Full Text] [Related]
18. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
Simmons LA; Havens JR
J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
[TBL] [Abstract][Full Text] [Related]
19. Consulting for substance abuse: mental disorders among adolescents and their parents.
Hodgins S; Tengström A; Bylin S; Göranson M; Hagen L; Janson M; Larsson A; Lundgren-Andersson C; Lundmark C; Norell E; Pedersen H
Nord J Psychiatry; 2007; 61(5):379-86. PubMed ID: 17990200
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS; Shepard DS
J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
